Sumner Andrew Slavin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 26 | 2013 | 1219 | 2.170 |
Why?
|
| Lymphedema | 16 | 2016 | 525 | 1.860 |
Why?
|
| Breast Implantation | 8 | 2014 | 222 | 1.510 |
Why?
|
| Surgical Flaps | 22 | 2011 | 1656 | 1.000 |
Why?
|
| Tissue Expansion | 6 | 2012 | 160 | 0.880 |
Why?
|
| Breast Implants | 10 | 2012 | 398 | 0.840 |
Why?
|
| Mastectomy | 15 | 2013 | 1816 | 0.680 |
Why?
|
| Breast | 10 | 2012 | 1968 | 0.640 |
Why?
|
| Collagen | 5 | 2013 | 2618 | 0.520 |
Why?
|
| Tissue Expansion Devices | 3 | 2012 | 157 | 0.510 |
Why?
|
| Esthetics | 8 | 2012 | 315 | 0.480 |
Why?
|
| Reoperation | 15 | 2013 | 4215 | 0.470 |
Why?
|
| Nipples | 4 | 2009 | 220 | 0.470 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 471 | 0.460 |
Why?
|
| Erythema | 1 | 2014 | 260 | 0.440 |
Why?
|
| Lipectomy | 5 | 2012 | 112 | 0.390 |
Why?
|
| Postoperative Complications | 10 | 2018 | 15341 | 0.350 |
Why?
|
| Cancer Care Facilities | 2 | 2009 | 417 | 0.340 |
Why?
|
| Abdominal Wall | 2 | 2007 | 164 | 0.320 |
Why?
|
| Skin Transplantation | 3 | 2012 | 1022 | 0.320 |
Why?
|
| Lymphocele | 1 | 2008 | 19 | 0.310 |
Why?
|
| Subcutaneous Fat | 2 | 2012 | 384 | 0.300 |
Why?
|
| Hospitals, Special | 1 | 2008 | 88 | 0.300 |
Why?
|
| Referral and Consultation | 5 | 2015 | 3543 | 0.290 |
Why?
|
| Rhytidoplasty | 1 | 2008 | 61 | 0.290 |
Why?
|
| Thigh | 1 | 2008 | 237 | 0.280 |
Why?
|
| Breast Neoplasms | 16 | 2012 | 20750 | 0.270 |
Why?
|
| Cicatrix | 3 | 2010 | 769 | 0.260 |
Why?
|
| Blepharoplasty | 1 | 2006 | 59 | 0.260 |
Why?
|
| Phlebotomy | 1 | 2005 | 136 | 0.250 |
Why?
|
| Hematoma | 2 | 2006 | 768 | 0.240 |
Why?
|
| Surgical Mesh | 1 | 2007 | 301 | 0.240 |
Why?
|
| Abdominal Muscles | 4 | 2007 | 166 | 0.230 |
Why?
|
| Hernia, Ventral | 1 | 2007 | 202 | 0.230 |
Why?
|
| Prosthesis Design | 1 | 2010 | 2103 | 0.230 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 313 | 0.220 |
Why?
|
| Program Development | 1 | 2009 | 1287 | 0.220 |
Why?
|
| Biocompatible Materials | 2 | 2011 | 1682 | 0.220 |
Why?
|
| Leg | 2 | 2012 | 1086 | 0.210 |
Why?
|
| Lymphatic System | 3 | 2007 | 248 | 0.200 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 626 | 0.200 |
Why?
|
| Rhinoplasty | 3 | 2012 | 233 | 0.190 |
Why?
|
| Female | 68 | 2016 | 382109 | 0.190 |
Why?
|
| Edema | 3 | 2012 | 755 | 0.180 |
Why?
|
| Endoscopy | 1 | 2010 | 1829 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 1161 | 0.170 |
Why?
|
| Patient Satisfaction | 7 | 2010 | 3408 | 0.170 |
Why?
|
| Algorithms | 3 | 2008 | 13796 | 0.160 |
Why?
|
| Muscle, Skeletal | 4 | 2007 | 4861 | 0.160 |
Why?
|
| Microsurgery | 3 | 2010 | 776 | 0.150 |
Why?
|
| Patient Selection | 1 | 2010 | 4191 | 0.150 |
Why?
|
| Transplantation Conditioning | 3 | 2002 | 1568 | 0.150 |
Why?
|
| Thoracic Wall | 2 | 2011 | 199 | 0.150 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 953 | 0.140 |
Why?
|
| Obesity | 3 | 2016 | 12670 | 0.140 |
Why?
|
| Surgery, Plastic | 4 | 2018 | 640 | 0.140 |
Why?
|
| Middle Aged | 40 | 2015 | 214412 | 0.140 |
Why?
|
| Adult | 44 | 2015 | 214958 | 0.140 |
Why?
|
| Scleroderma, Localized | 1 | 1997 | 85 | 0.140 |
Why?
|
| Humans | 75 | 2018 | 746044 | 0.140 |
Why?
|
| Mastectomy, Segmental | 3 | 2006 | 956 | 0.130 |
Why?
|
| Facial Neoplasms | 2 | 1989 | 119 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2015 | 12633 | 0.130 |
Why?
|
| Lipomatosis | 2 | 1989 | 112 | 0.130 |
Why?
|
| Contraceptives, Oral | 1 | 2018 | 550 | 0.130 |
Why?
|
| Syndrome | 2 | 2014 | 3245 | 0.120 |
Why?
|
| Models, Animal | 1 | 2001 | 2110 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2014 | 2025 | 0.120 |
Why?
|
| Surgical Sponges | 1 | 2014 | 40 | 0.120 |
Why?
|
| Mastectomy, Modified Radical | 2 | 2009 | 62 | 0.120 |
Why?
|
| Silicones | 1 | 1995 | 228 | 0.110 |
Why?
|
| Cost of Illness | 2 | 2014 | 1878 | 0.110 |
Why?
|
| Medical Tourism | 1 | 2014 | 51 | 0.110 |
Why?
|
| Lymphography | 2 | 2008 | 188 | 0.110 |
Why?
|
| Implant Capsular Contracture | 1 | 2012 | 23 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3258 | 0.110 |
Why?
|
| Implants, Experimental | 1 | 2012 | 99 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2000 | 1053 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5218 | 0.100 |
Why?
|
| Foreign-Body Reaction | 1 | 2012 | 156 | 0.100 |
Why?
|
| Skin, Artificial | 1 | 2012 | 89 | 0.100 |
Why?
|
| Axilla | 2 | 2011 | 604 | 0.090 |
Why?
|
| Tensile Strength | 2 | 2013 | 330 | 0.090 |
Why?
|
| Lipodystrophy | 1 | 2012 | 145 | 0.090 |
Why?
|
| Costs and Cost Analysis | 3 | 2012 | 1656 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1998 | 1083 | 0.090 |
Why?
|
| Nasal Obstruction | 1 | 2012 | 158 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2008 | 1978 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2014 | 388 | 0.090 |
Why?
|
| New England | 2 | 2009 | 1027 | 0.090 |
Why?
|
| Connective Tissue Diseases | 1 | 2012 | 275 | 0.080 |
Why?
|
| Quality of Life | 5 | 2014 | 12984 | 0.080 |
Why?
|
| Materials Testing | 1 | 2012 | 850 | 0.080 |
Why?
|
| Fat Necrosis | 1 | 2008 | 60 | 0.080 |
Why?
|
| Graft Survival | 5 | 2009 | 3599 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 15537 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 847 | 0.080 |
Why?
|
| Occlusive Dressings | 1 | 2008 | 51 | 0.080 |
Why?
|
| Lower Extremity | 2 | 2015 | 1176 | 0.080 |
Why?
|
| Regeneration | 1 | 1997 | 1492 | 0.080 |
Why?
|
| Groin | 1 | 2008 | 102 | 0.080 |
Why?
|
| Horses | 1 | 2008 | 295 | 0.070 |
Why?
|
| Safety | 2 | 2005 | 1146 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1354 | 0.070 |
Why?
|
| Neck | 1 | 2012 | 703 | 0.070 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 410 | 0.070 |
Why?
|
| Treatment Outcome | 10 | 2012 | 63661 | 0.070 |
Why?
|
| Fingers | 2 | 1988 | 503 | 0.070 |
Why?
|
| Penile Diseases | 1 | 2007 | 45 | 0.070 |
Why?
|
| Medical Records | 2 | 2009 | 1390 | 0.070 |
Why?
|
| Retrobulbar Hemorrhage | 1 | 2006 | 11 | 0.070 |
Why?
|
| Fascia | 1 | 2007 | 141 | 0.070 |
Why?
|
| Varicose Veins | 1 | 1988 | 153 | 0.070 |
Why?
|
| Male | 24 | 2016 | 351093 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2015 | 78297 | 0.070 |
Why?
|
| Peritoneum | 1 | 2007 | 222 | 0.070 |
Why?
|
| Aged | 17 | 2015 | 164236 | 0.070 |
Why?
|
| Malpractice | 1 | 2010 | 550 | 0.070 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2007 | 211 | 0.070 |
Why?
|
| Radiotherapy | 1 | 1992 | 1504 | 0.060 |
Why?
|
| Breast Diseases | 2 | 2006 | 443 | 0.060 |
Why?
|
| Cocaine | 1 | 1990 | 982 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 450 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2000 | 5465 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1771 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2012 | 38752 | 0.060 |
Why?
|
| Laparotomy | 1 | 2007 | 460 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1998 | 608 | 0.060 |
Why?
|
| Muscles | 1 | 1989 | 1583 | 0.060 |
Why?
|
| Extremities | 2 | 2007 | 849 | 0.060 |
Why?
|
| Cysts | 1 | 1989 | 675 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 465 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2001 | 3581 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 1998 | 9170 | 0.060 |
Why?
|
| Drainage | 1 | 1989 | 1142 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2007 | 732 | 0.050 |
Why?
|
| Skin | 2 | 1993 | 4390 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 1442 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2007 | 2109 | 0.050 |
Why?
|
| Bone Marrow Purging | 2 | 2002 | 106 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 786 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 1999 | 17834 | 0.050 |
Why?
|
| Vidarabine | 1 | 2002 | 333 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 1 | 2002 | 279 | 0.050 |
Why?
|
| Adolescent | 10 | 2015 | 86202 | 0.050 |
Why?
|
| Face | 1 | 2007 | 1009 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1768 | 0.050 |
Why?
|
| Health Care Surveys | 3 | 2014 | 2416 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2008 | 1034 | 0.050 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 375 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2000 | 70 | 0.050 |
Why?
|
| Wound Healing | 3 | 2007 | 2748 | 0.050 |
Why?
|
| Weight Loss | 1 | 2012 | 2636 | 0.050 |
Why?
|
| Family | 1 | 2010 | 3156 | 0.040 |
Why?
|
| Fibrosis | 1 | 2006 | 2005 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2008 | 1163 | 0.040 |
Why?
|
| Carcinoma in Situ | 2 | 2008 | 797 | 0.040 |
Why?
|
| Defecation | 1 | 1979 | 189 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1999 | 817 | 0.040 |
Why?
|
| Logistic Models | 2 | 2009 | 13164 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3037 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2000 | 604 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12839 | 0.040 |
Why?
|
| Technetium Compounds | 1 | 1997 | 15 | 0.040 |
Why?
|
| Hand | 1 | 1983 | 876 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 1997 | 55 | 0.040 |
Why?
|
| Antimony | 1 | 1997 | 19 | 0.040 |
Why?
|
| Sepsis | 2 | 1983 | 2589 | 0.040 |
Why?
|
| Colloids | 1 | 1997 | 133 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2014 | 1694 | 0.040 |
Why?
|
| Random Allocation | 1 | 2001 | 2385 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6298 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2018 | 254 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 1983 | 701 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 1235 | 0.030 |
Why?
|
| Lectins | 1 | 1997 | 480 | 0.030 |
Why?
|
| Methods | 2 | 1988 | 1081 | 0.030 |
Why?
|
| Young Adult | 5 | 2015 | 57106 | 0.030 |
Why?
|
| Consensus | 1 | 2004 | 3011 | 0.030 |
Why?
|
| Risk Factors | 3 | 2010 | 72416 | 0.030 |
Why?
|
| Nose | 2 | 2012 | 510 | 0.030 |
Why?
|
| Back | 1 | 1994 | 64 | 0.030 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 23 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1161 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 1994 | 86 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 4294 | 0.030 |
Why?
|
| Animals | 7 | 2012 | 166331 | 0.030 |
Why?
|
| Transplantation, Homologous | 3 | 2000 | 4617 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2018 | 602 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1872 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 1993 | 56 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5821 | 0.030 |
Why?
|
| Bandages | 2 | 2006 | 261 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8486 | 0.030 |
Why?
|
| Feces | 1 | 1979 | 1429 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 1997 | 397 | 0.030 |
Why?
|
| Prognosis | 3 | 2015 | 29068 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 6781 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 1998 | 712 | 0.020 |
Why?
|
| Graft vs Host Disease | 2 | 2002 | 2931 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1624 | 0.020 |
Why?
|
| Staphylococcus | 2 | 1983 | 155 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 23453 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2013 | 514 | 0.020 |
Why?
|
| Specialization | 1 | 2015 | 767 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 2918 | 0.020 |
Why?
|
| Blindness | 1 | 2014 | 582 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2006 | 8511 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2258 | 0.020 |
Why?
|
| Cause of Death | 1 | 2000 | 3615 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3966 | 0.020 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 103 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 490 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25177 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2842 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1990 | 468 | 0.020 |
Why?
|
| Survival Rate | 2 | 2000 | 12632 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1837 | 0.020 |
Why?
|
| Acute Disease | 1 | 1999 | 7116 | 0.020 |
Why?
|
| Recurrence | 1 | 2000 | 8373 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1255 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 98 | 0.020 |
Why?
|
| Hernia | 1 | 1988 | 68 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1265 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1989 | 286 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1999 | 3448 | 0.020 |
Why?
|
| Sensation | 1 | 2009 | 331 | 0.020 |
Why?
|
| Health Status | 2 | 2012 | 4016 | 0.020 |
Why?
|
| Scrotum | 1 | 2007 | 115 | 0.020 |
Why?
|
| Carcinoma | 1 | 1998 | 2344 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 11064 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 1594 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6732 | 0.020 |
Why?
|
| Perineum | 1 | 2007 | 208 | 0.020 |
Why?
|
| Paraplegia | 1 | 2006 | 164 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9105 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1993 | 3584 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3426 | 0.020 |
Why?
|
| Time Factors | 4 | 2007 | 39587 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2006 | 186 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2006 | 153 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 1629 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 968 | 0.020 |
Why?
|
| Posture | 1 | 1989 | 949 | 0.020 |
Why?
|
| Spinal Dysraphism | 1 | 2006 | 167 | 0.020 |
Why?
|
| Cellulitis | 1 | 2006 | 212 | 0.020 |
Why?
|
| Rats | 2 | 1999 | 23680 | 0.010 |
Why?
|
| Thorax | 1 | 2007 | 543 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2012 | 53218 | 0.010 |
Why?
|
| Health Education | 1 | 2010 | 1045 | 0.010 |
Why?
|
| Enterobacter | 1 | 1983 | 46 | 0.010 |
Why?
|
| Biological Dressings | 1 | 1982 | 29 | 0.010 |
Why?
|
| Body Image | 1 | 2008 | 623 | 0.010 |
Why?
|
| Mice | 2 | 2001 | 80087 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1804 | 0.010 |
Why?
|
| Child | 4 | 2015 | 78456 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20142 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 891 | 0.010 |
Why?
|
| Plethysmography | 1 | 1983 | 173 | 0.010 |
Why?
|
| Thermography | 1 | 1983 | 65 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2008 | 5899 | 0.010 |
Why?
|
| Streptococcus | 1 | 1983 | 197 | 0.010 |
Why?
|
| Raynaud Disease | 1 | 1983 | 73 | 0.010 |
Why?
|
| United States | 3 | 2018 | 70383 | 0.010 |
Why?
|
| Premedication | 1 | 1983 | 254 | 0.010 |
Why?
|
| Mammography | 1 | 1992 | 2425 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 930 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1983 | 440 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1982 | 448 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2015 | 40503 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 588 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7271 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1982 | 509 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6220 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2006 | 752 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13538 | 0.010 |
Why?
|
| Aneurysm | 1 | 1983 | 336 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57557 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5688 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 35784 | 0.010 |
Why?
|
| Electromyography | 1 | 1983 | 1374 | 0.010 |
Why?
|
| Body Composition | 1 | 2007 | 2381 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 2 | 2002 | 2676 | 0.010 |
Why?
|
| Plant Lectins | 1 | 1997 | 102 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 1596 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2198 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1982 | 4091 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2006 | 1403 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 3187 | 0.010 |
Why?
|
| Decision Making | 1 | 2010 | 3855 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1989 | 41376 | 0.010 |
Why?
|
| Ischemia | 1 | 1983 | 1857 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1982 | 2218 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 3984 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1999 | 2614 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 7810 | 0.010 |
Why?
|
| Fees, Medical | 1 | 1993 | 113 | 0.010 |
Why?
|
| Remission Induction | 1 | 1997 | 2361 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 3539 | 0.010 |
Why?
|
| Burns | 1 | 1982 | 1846 | 0.010 |
Why?
|
| Cost Control | 1 | 1993 | 623 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10127 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13303 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2002 | 11539 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2130 | 0.010 |
Why?
|
| Thrombosis | 1 | 1983 | 2999 | 0.000 |
Why?
|
| Palliative Care | 1 | 1983 | 3548 | 0.000 |
Why?
|
| Hindlimb | 1 | 1990 | 501 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4816 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1270 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1983 | 7222 | 0.000 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1982 | 224 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1981 | 488 | 0.000 |
Why?
|
| Dogs | 1 | 1981 | 3820 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9116 | 0.000 |
Why?
|
| Radiation Dosage | 1 | 1982 | 1952 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1982 | 2901 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1982 | 5413 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 7935 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 10018 | 0.000 |
Why?
|